Stock CLS B CLINICAL LASERTHERMIA SYSTEMS AB
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Clinical Laserthermia Systems AB

Equities

CLS B

SE0022049920

Market Closed - Nasdaq Stockholm
Other stock markets
 17:00:00 24/06/2024 BST 		5-day change 1st Jan Change
5.997 SEK -1.19% Intraday chart for Clinical Laserthermia Systems AB -1.67% -78.27%
06-24 Clinical Laserthermia Systems AB Announces Completion of Clinical Study At Skane University Hospital CI
06-20 Clinical Laserthermia Systems AB Receives Additional Order for Clearpoint Prism Products Associated to Approximately SEK 7.5 Million CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Clinical Laserthermia Systems AB Announces Completion of Clinical Study At Skane University Hospital
Clinical Laserthermia Systems AB Receives Additional Order for Clearpoint Prism Products Associated to Approximately SEK 7.5 Million
Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue
Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with MTEC Company
Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory
Clinical Laserthermia Systems AB Presents Initial Data from the Investigator Initiated Trial at Radboud University Medical Center Using the CLS Transberg System
Clinical Laserthermia Systems Receives Second Order from the National Institutes of Health Clinical Center in the US for its TRANBERG Thermal Therapy System Accessories
Clinical Laserthermia Systems AB Announces Two Patients with Localized Prostate Cancer Have Been Safely Treated with the Tranberg Thermal Therapy System At the San Luigi Gonzaga University Hospital in Turin, Italy
Clinical Laserthermia Systems AB's Subsidiary CLS Americas Signs Agreement with ROSE Urology for Treatment of Prostate Cancer Patients with TRANBERG Thermal Therapy System
Clinical Laserthermia Systems Names Interim CFO
Clinical Laserthermia Systems AB Announces Publication of Preclinical Assessment of A Non-Cooled MR Thermometry-Based Neurosurgical Laser Therapy System
Clinical Laserthermia Systems AB Reports Earnings Results for the Full Year Ended December 31, 2023
Clinical Laserthermia Systems AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Clinical Laserthermia Systems Gains Underwriting Commitments for Warrant Series Exercise
Clinical Laserthermia Systems Files Patent Extension, Expansion for Non-cooled Laser Applicators
Clinical Laserthermia Systems AB Files A New Patent Application for Expanded and Extended Protection of the Company's Technology for Laser-Based Tissue Ablation Until 2044
Clinical Laserthermia Systems Prices Warrants; Stock Falls
Clinical Laserthermia Systems AB Future-Proofs its Core Technology for MRI-Guided Laser Ablation in A New Agreement with Image Guided Therapy SA
Clinical Laserthermia Systems Obtains Marketing Approval for Tranberg Thermal Therapy Portfolio in Singapore
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLS B Stock
  4. News Clinical Laserthermia Systems AB
  5. Other languages